SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-041673
Filing Date
2023-07-06
Accepted
2023-07-06 18:37:54
Documents
1
Period of Report
2023-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3510
  Complete submission text file 0001209191-23-041673.txt   4917
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20 BERKELEY SQUARE, MAYFAIR LONDON X0 W1J 6EQ
Business Address
Chin Mark (Reporting) CIK: 0001734389 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38800 | Film No.: 231074810